[1] |
LUO C, LEI M, ZHANG Y, et al. Systematic construction and validation of an immune prognostic model for lung adenocarcinoma[J]. J Cell Mol Med, 2020, 24(2): 1233-1244.
doi: 10.1111/jcmm.v24.2
|
[2] |
KLECZKO E K, KWAK J W, SCHENK E L, et al. Targeting the complement pathway as a therapeutic strategy in lung cancer[J]. Front Immunol, 2019, 10: 954.
doi: 10.3389/fimmu.2019.00954
|
[3] |
YAN J L, ZHOU B H, GUO L, et al. GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma[J]. Am J Cancer Res, 2020, 10(11): 3705-3720.
|
[4] |
郑兴, 吴兆红, 陈岗东, 等. miRNA27a靶向GOLM1对非小细胞肺癌生物行为学的影响[J]. 中国免疫学杂志, 2020, 36(1): 52-56.
|
|
ZHENG X, WU Z H, CHEN G D, et al. Effect of miRNA27a targeting GOLM1 on biobehavioral of non-small cell lung cancer[J]. Chin J Immunol, 2020, 36(1): 52-56.
|
[5] |
曾建昌, 刘艳, 杨俊, 等. 复方苦参注射液联合奥希替尼介导PI3K/AKT/mTOR信号通路在肺腺癌细胞H1975中的作用机制[J]. 中国免疫学杂志, 2021, 37(10): 1191-1195.
|
|
ZENG J C, LIU Y, YANG J, et al. Mechanism of compound sophora flavescens injection combined with osimertinib in lung adenocarcinoma cell H1975 via PI3K/AKT/mTOR signaling pathway[J]. Chin J Immunol, 2021, 37(10): 1191-1195.
|
[6] |
王永贵. SLC25A22在骨肉瘤组织中的表达及其与预后的相关性[J]. 现代肿瘤医学, 2021, 29(17): 3093-3096.
|
|
WANG Y G. Expression of SLC25A22 in osteosarcoma and its correlation with prognosis[J]. J Mod Oncol, 2021, 29(17): 3093-3096.
|
[7] |
RONG L, LI Z D, LENG X, et al. Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K/AKT/mTOR pathway[J]. Biomed Pharmacother, 2020, 122: 109726.
doi: 10.1016/j.biopha.2019.109726
|
[8] |
WANG Y Q, HUANG J, WU Q, et al. Downregulation of breast cancer resistance protein by long-term fractionated radiotherapy sensitizes lung adenocarcinoma to SN-38[J]. Invest New Drugs, 2021, 39(2): 458-468.
doi: 10.1007/s10637-020-01003-3
|
[9] |
ZHANG R, ZHU Z, SHEN W Z, et al. Golgi membrane protein 1 (GOLM1) promotes growth and metastasis of breast cancer cells via regulating matrix metalloproteinase-13 (MMP13)[J]. Med Sci Monit, 2019, 25: 847-855.
doi: 10.12659/MSM.911667
|
[10] |
YE Q H, ZHU W W, ZHANG J B, et al. GOLM1 modulates EGFR/RTK cell-surface recycling to drive hepatocellular carcinoma metastasis[J]. Cancer Cell, 2016, 30(3): 444-458.
doi: 10.1016/j.ccell.2016.07.017
|
[11] |
翟维佳, 封全灵, 张慧芳, 等. GOLM1对宫颈癌上皮间质转化的影响及其与临床病理特征的关系[J]. 肿瘤学杂志, 2019, 25(11): 976-979.
|
|
ZHAI W J, FENG Q L, ZHANG H F, et al. Effect of GOLM1 expression on epithelial-mesenchymal transition and its relationship with clinicopathological features of cervical cancer[J]. J Chin Oncol, 2019, 25(11): 976-979.
|
[12] |
余展鹏, 江雁琼. 基于数据挖掘分析GOLM1基因在前列腺癌中的表达及其临床意义[J]. 中国癌症防治杂志, 2019, 11(2): 158-162.
|
|
YU Z P, JIANG Y Q. Analysis of GOLM1 gene expression in prostate cancer and its effect on prognosis based on data mining[J]. Chin J Oncol Prev Treat, 2019, 11(2): 158-162.
|
[13] |
ARUNA, LI L M. Overexpression of Golgi membrane protein 1 promotes non-small-cell carcinoma aggressiveness by regulating the matrix metallopeptidase 13[J]. Am J Cancer Res, 2018, 8(3): 551-565.
|
[14] |
ZHANG S K, GE W M, ZOU G Y, et al. MiR-382 targets GOLM1 to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival[J]. Am J Cancer Res, 2018, 8(1): 120-131.
|
[15] |
YANG L Q, LUO P C, SONG Q, et al. DNMT1/miR-200a/GOLM1 signaling pathway regulates lung adenocarcinoma cells proliferation[J]. Biomedecine Pharmacother, 2018, 99: 839-847.
|
[16] |
CIRONE M. Cancer cells dysregulate PI3K/AKT/mTOR pathway activation to ensure their survival and proliferation: mimicking them is a smart strategy of gammaherpesviruses[J]. Crit Rev Biochem Mol Biol, 2021, 56(5): 500-509.
doi: 10.1080/10409238.2021.1934811
|
[17] |
GU Z H, YOU Z X, YANG Y C, et al. Inhibition of MicroRNA miR-101-3p on prostate cancer progression by regulating cullin 4B (CUL4B) and PI3K/AKT/mTOR signaling pathways[J]. Bioengineered, 2021, 12(1): 4719-4735.
doi: 10.1080/21655979.2021.1949513
|
[18] |
DENG L, WU X R, ZHU X J, et al. Combination effect of curcumin with docetaxel on the PI3K/AKT/mTOR pathway to induce autophagy and apoptosis in esophageal squamous cell carcinoma[J]. Am J Transl Res, 2021, 13(1): 57-72.
|
[19] |
炎士珂, 冯婧文, 昌娇, 等. FGFC1经PI3K/AKT/mTOR途径抑制非小细胞肺癌细胞增殖和迁移[J]. 中国生物化学与分子生物学报, 2021, 37(8): 1069-1077.
|
|
YAN S K, FENG J W, CHANG J, et al. FGFC1 inhibits proliferation and migration of non-small cell lung cancer cells via the PI3K/AKT/mTOR signaling pathway[J]. Chin J Biochem Mol Biol, 2021, 37(8): 1069-1077.
|
[20] |
孟东雪, 郭玉荣, 罗斌军, 等. 扶正抑瘤汤通过PI3K/AKT/mTOR信号通路抑制非小细胞肺癌增殖、凋亡及自噬[J]. 中国癌症防治杂志, 2021, 13(2): 177-182.
|
|
MENG D X, GUO Y R, LUO B J, et al. Fuzheng Yiliu decoction inhibits the proliferation, apoptosis and autophagy of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway[J]. Chin J Oncol Prev Treat, 2021, 13(2): 177-182.
|
[21] |
丁志丹, 方泽民, 王旭广, 等. 贝母素乙调控PI3K/AKT/mTOR通路减缓上皮-间质转化进程抑制人肺癌A549细胞侵袭及迁移的研究[J]. 中草药, 2019, 50(6): 1382-1387.
|
|
DING Z D, FANG Z M, WANG X G, et al. Inhibition of peiminine on invasion and migration of human lung cancer A549 cells by decreasing epithelial-mesenchymal transition process via PI3K/AKT/mTOR pathway[J]. Chin Tradit Herb Drugs, 2019, 50(6): 1382-1387.
|